Literature DB >> 30651409

Serum Triglyceride Lipase Concentrations are Independent Risk Factors for Coronary Artery Disease and In-Stent Restenosis.

Xiaolan Yu1, Jianping Lu2, Jingjing Li3, Wen Guan4, Shaorong Deng3, Qing Deng1, Hao Ye3, Wei Han3, Yan Yu1, Ruiyan Zhang5.   

Abstract

AIM: Endothelial lipase (EL), hepatic lipase (HL), and lipoprotein lipase (LPL) are all triglyceride lipases and are associated with coronary artery disease (CAD). However, whether they can be simultaneous independent risk factors for CAD is unknown. In the present study, we investigated whether the three lipases can be independent risk factors simultaneously for CAD and whether combining these lipases could provide greater predictive power than high-density lipoprotein cholesterol (HDL-c) for the development of CAD.
METHODS: Eighty-six patients with CAD and 65 healthy controls were enrolled in the study. Additionally, 38 patients who underwent one-year follow-up angiography after percutaneous coronary intervention with stent implantation were collected to investigate in-stent restenosis. Serum EL, HL, and LPL concentrations were measured and compared with other coronary risk factors.
RESULTS: Serum EL and HL concentrations were both significantly increased in patients with CAD or in-stent restenosis, whereas serum LPL concentration was reduced significantly in patients with CAD. Multivariate logistic regression analysis indicated that the three lipases were simultaneous independent risk factors for CAD. However, only serum EL concentration was considered an independent risk factor for in-stent restenosis. Importantly, the receiver operating characteristic curve showed that the combined measurement of the three lipases displayed better predictive power than HDL-c or any one of the three lipases for CAD.
CONCLUSIONS: Serum EL concentration was an independent risk factor for both CAD and in-stent restenosis. Moreover, the combined assessment of serum EL, HL, and LPL concentrations as multiple risk factors provided potent predictive power for CAD.

Entities:  

Keywords:  Coronary artery disease; Endothelial lipase; Hepatic lipase; In-stent restenosis; Lipoprotein lipase; Risk factor

Mesh:

Substances:

Year:  2019        PMID: 30651409      PMCID: PMC6753239          DOI: 10.5551/jat.46821

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  3 in total

1.  Endothelial Lipase Exerts its Anti-Atherogenic Effect through Increased Catabolism of β-VLDLs.

Authors:  Haizhao Yan; Manabu Niimi; Chuan Wang; Yajie Chen; Huanjin Zhou; Fumikazu Matsuhisa; Kazutoshi Nishijima; Shuji Kitajima; Bo Zhang; Hiroshi Yokomichi; Katsuyuki Nakajima; Masami Murakami; Jifeng Zhang; Y Eugene Chen; Jianglin Fan
Journal:  J Atheroscler Thromb       Date:  2020-05-23       Impact factor: 4.928

2.  Predictors of recurrent acute myocardial infarction despite successful percutaneous coronary intervention.

Authors:  Sang Hun Lee; Myung Ho Jeong; Joon Ho Ahn; Dae Young Hyun; Kyung Hoon Cho; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Jin Yong Hwang; Weon Kim; Jong Seon Park; Chang-Hwan Yoon; Seung Ho Hur; Sang Rok Lee; Kwang Soo Cha
Journal:  Korean J Intern Med       Date:  2022-06-28       Impact factor: 3.165

3.  Implications of C1q/TNF-related protein superfamily in patients with coronary artery disease.

Authors:  Yanwei Zhang; Caihong Liu; Jing Liu; Rui Guo; Zheyi Yan; Wenxia Liu; Wayne Bond Lau; Xiangying Jiao; Jimin Cao; Kun Xu; Yongping Jia; Xinliang Ma; Yajing Wang
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.